KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Share-based Compensation (2016 - 2025)

Exact Sciences (EXAS) has disclosed Share-based Compensation for 16 consecutive years, with $55.6 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 13.09% to $55.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $217.7 million through Dec 2025, up 1.29% year-over-year, with the annual reading at $217.7 million for FY2025, 1.29% up from the prior year.
  • Share-based Compensation for Q4 2025 was $55.6 million at Exact Sciences, up from $51.6 million in the prior quarter.
  • The five-year high for Share-based Compensation was $77.3 million in Q1 2021, with the low at $1.0 million in Q2 2021.
  • Average Share-based Compensation over 5 years is $50.5 million, with a median of $55.1 million recorded in 2025.
  • The sharpest move saw Share-based Compensation crashed 97.5% in 2021, then skyrocketed 5793.2% in 2022.
  • Over 5 years, Share-based Compensation stood at $55.9 million in 2021, then decreased by 17.83% to $45.9 million in 2022, then increased by 27.57% to $58.6 million in 2023, then decreased by 16.0% to $49.2 million in 2024, then rose by 13.09% to $55.6 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $55.6 million, $51.6 million, and $55.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.